Cx26 gene mutations in idiopathic progressive hearing loss

Area of Science:

• Genetics
• Audiology
• Molecular Biology

Background:

• Progressive hearing loss, often idiopathic, affects numerous individuals.
• The GJB2 gene, encoding connexin 26 (Cx26), is a known factor in hearing impairment.
• Understanding GJB2 mutation prevalence is crucial for diagnosing hearing loss.

Purpose of the Study:

• To determine the frequency and types of GJB2 gene mutations in patients with sporadic progressive idiopathic hearing loss.
• To investigate the role of GJB2 mutations in the etiology of hearing loss.
• To assess the diagnostic utility of GJB2 molecular analysis in affected individuals.

Main Methods:

• Genomic DNA sequencing of the entire GJB2 gene in 39 patients with sporadic progressive idiopathic hearing loss.
• Screening for GJB6 (Cx30) mutations and mitochondrial DNA A1555G mutation in patients with Cx26 mutations.
• Analysis of GJB2 mutations in a control group of 40 individuals.

Main Results:

• GJB2 mutations were identified in 23% (9/39) of the patient cohort.
• Common mutations included 35delG, E47X, L90P, R127H, M34T, V153I, and V37I.
• No GJB6 or mitochondrial DNA mutations were found in patients with GJB2 mutations. Two individuals (5%) in the control group had GJB2 mutations.

Conclusions:

• GJB2 mutations are a significant factor in sporadic progressive idiopathic hearing loss.
• Heterozygous GJB2 genotypes may contribute to hearing loss, potentially with other genetic factors.
• Molecular analysis of GJB2 is recommended for adult patients with idiopathic progressive hearing loss, with continued monitoring for those with identified mutations.